WUXI BIO (HKEX: 02269) has announced a significant share repurchase transaction.
The company disclosed that on June 12, 2026, it utilized approximately HK$99.78 million to repurchase 3.269 million of its own shares.
In a separate corporate action on the same date, the company issued 21,000 new shares.
These shares were issued pursuant to the exercise of options under a pre-IPO share option scheme adopted on January 5, 2016, and subsequently amended on August 10, 2016.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.